Kato Shinya, Yoshitani Kenji, Kubota Yosuke, Inatomi Yuzuru, Ohnishi Yoshihiko
Department of Anesthesiology, National Cerebral and Cardiovascular Center, Fujishirodai, Suita, Osaka, 565-8565, Japan.
Department of Anesthesiology, Tokyo Medical University, Nishi-Shinjuku, Shinjuku, Tokyo, 160-0023, Japan.
J Anesth. 2017 Feb;31(1):103-110. doi: 10.1007/s00540-016-2275-1. Epub 2016 Nov 2.
Near-infrared spectroscopy (NIRS)-based cerebral oximetry is a noninvasive technology used to estimate regional cerebral oxygen saturation (rSO). Extracranial blood flow is known to substantially affect rSO values measured by most clinically available devices. Several studies have also reported that the Trendelenburg position and upright position have a larger effect on rSO measurements than the supine position. Therefore, we investigated the effect of these two positions (the Trendelenburg position versus the upright position) and extracranial contamination on rSO measurements obtained using two commercially available devices and one prototype device.
Twelve healthy volunteers were enrolled in the study. They each had three cerebral oximetry devices applied to their forehead (FORE-SIGHT ELITE™, CAS Medical Systems Inc., Branford, CT, USA; INVOS 5100c™, Medtronic, Minneapolis, MN, USA; and NIRO-TRS, Hamamatsu Photonics, Hamamatsu, Japan). A circumferential pneumatic head cuff was positioned proximal to the NIRS cerebral oximetry sensors. We measured rSO, heart rate (HR), and blood pressure (BP) in six conditions (supine, Trendelenburg and upright positions, with and without scalp ischemia induced by head cuff inflation) every 5 min with each oximetry device. Total hemoglobin (tHb), which is associated with cerebral blood volume (CBV) as measured by positron emission tomography, was measured using the NIRO-TRS device to determine extracranial blood volume in each position.
Measurements of rSO with all the devices were affected by extracranial contamination. The percentage of extracranial contamination was highest with INVOS 5100c™ in the upright position (INVOS, 21.3%; FORE-SIGHT, 14.3%; NIRO-TRS, 3.6%). Measurements of rSO obtained in the upright position were significantly lower than those obtained in the supine position, using INVOS-5100c™ and FORE-SIGHT ELITE™ (71 vs. 74% and 67 vs. 72%, respectively), but not using NIRO-TRS (62 vs. 64%). A significant decrease in tHb was observed after head cuff inflation in the supine and Trendelenburg positions (supine, 0.132-0.123 μmol/l; Trendelenburg, 0.133-0.125 μmol/l).
Except when using NIRO-TRS, measurements of rSO in the forehead are significantly lower when measured in the upright position than in the supine position. All devices in this study were affected by extracranial contamination.
基于近红外光谱(NIRS)的脑氧饱和度测定是一种用于估计局部脑氧饱和度(rSO)的无创技术。已知颅外血流会显著影响大多数临床可用设备测量的rSO值。多项研究还报告称,与仰卧位相比,头低脚高位和直立位对rSO测量的影响更大。因此,我们研究了这两种体位(头低脚高位与直立位)以及颅外污染对使用两种商用设备和一种原型设备获得的rSO测量值的影响。
12名健康志愿者参与了本研究。他们每个人的前额都应用了三种脑氧饱和度测定设备(FORE-SIGHT ELITE™,美国康涅狄格州布兰福德市CAS医疗系统公司;INVOS 5100c™,美国明尼苏达州明尼阿波利斯市美敦力公司;以及日本滨松市滨松光子学公司的NIRO-TRS)。在NIRS脑氧饱和度测定传感器近端放置一个环形充气式头部袖带。我们使用每种氧饱和度测定设备,每隔5分钟在六种条件下(仰卧位、头低脚高位和直立位,头部袖带充气和未充气诱导头皮缺血)测量rSO、心率(HR)和血压(BP)。使用NIRO-TRS设备测量总血红蛋白(tHb),其与正电子发射断层扫描测量的脑血容量(CBV)相关,以确定每个体位的颅外血容量。
所有设备测量的rSO均受颅外污染影响。在直立位时,INVOS 5100c™的颅外污染百分比最高(INVOS为21.3%;FORE-SIGHT为14.3%;NIRO-TRS为3.6%)。使用INVOS-5100c™和FORE-SIGHT ELITE™时,直立位测量的rSO显著低于仰卧位测量的rSO(分别为71%对74%和67%对72%),但使用NIRO-TRS时并非如此(62%对64%)。在仰卧位和头低脚高位,头部袖带充气后观察到tHb显著下降(仰卧位,从0.132 μmol/l降至0.123 μmol/l;头低脚高位,从0.133 μmol/l降至0.125 μmol/l)。
除使用NIRO-TRS外,前额rSO在直立位测量时显著低于仰卧位测量时。本研究中的所有设备均受颅外污染影响。